Ventilation-Perfusion Matching

The ventilation-perfusion ratio (V̇/Q̇) is the ratio of alveolar ventilation to pulmonary capillary blood flow in a given region of lung, normally expressed per minute (L/min ventilation ÷ L/min perfusion). For the lung as a whole, alveolar ventilation is about 4 L/min and cardiac output (pulmonary blood flow) is about 5 L/min, giving a whole-lung average V̇/Q̇ ≈ 0.8. But this average conceals enormous regional variation: individual alveolar units in an upright human lung have V̇/Q̇ ratios spanning from below 0.1 at the base to above 3 at the apex. The physiological importance of this ratio is that it — not ventilation or perfusion alone — determines the partial pressures of O2 and CO2 that blood leaving any given alveolus will carry. Two limiting cases define the pathological extremes. A shunt is an alveolar unit with perfusion but no ventilation (V̇/Q̇ = 0): blood passes through without picking up oxygen, emerging with the composition of mixed venous blood. Dead space (alveolar dead space, not anatomical) is a unit with ventilation but no perfusion (V̇/Q̇ = ∞): fresh air is moved in and out but no gas exchange occurs, wasting ventilatory effort. Real lungs, healthy or diseased, contain a continuous distribution of units between these extremes, and the shape of that distribution — not simply its mean — determines overall gas exchange efficiency. Matching becomes a physiological priority because O2 and CO2 exchange are both nonlinear functions of V̇/Q̇, and — critically — a high-V̇/Q̇ region cannot fully compensate for a low-V̇/Q̇ region in the same lung. This asymmetry, explained mechanistically below, is why V̇/Q̇ mismatch causes hypoxemia disproportionately, and why the lung evolved active mechanisms — hypoxic pulmonary vasoconstriction chief among them — to minimize mismatch rather than simply tolerate it. Understanding Gas Exchange & Diffusion explains what happens once gas crosses the membrane; V/Q matching explains whether gas gets the chance to cross at all.

Step 1 — Why V̇/Q̇ determines alveolar gas composition. Consider a single alveolar-capillary unit. Blood enters as mixed venous blood (PvO2 ≈ 40 mmHg, PvCO2 ≈ 45 mmHg) and equilibrates with alveolar gas, whose composition depends on the balance between fresh air delivery (ventilation) replenishing O2 and washing out CO2, versus blood flow (perfusion) removing O2 and adding CO2. If V̇/Q̇ is high (lots of air, little blood), each unit of blood equilibrates with gas close to inspired air composition (PO2 → 150 mmHg, PCO2 → 0). If V̇/Q̇ is low (little air, lots of blood), alveolar gas is dragged toward venous composition (PO2 → 40, PCO2 → 45). This relationship is captured quantitatively by the O2-CO2 diagram, plotting alveolar PO2 against PCO2 as V̇/Q̇ varies continuously from 0 (venous point) to ∞ (inspired-air point).

Step 2 — Why mismatch hurts O2 more asymmetrically than it first appears. Because of the shapes of the O2 and CO2 dissociation curves, a small number of low-V̇/Q̇ units can drag down arterial O2 content substantially, while high-V̇/Q̇ units cannot proportionally raise it. This is because hemoglobin is nearly saturated at normal alveolar PO2 (~100 mmHg); a high-V̇/Q̇ unit pushing PO2 up to 130 mmHg adds almost no extra O2 content (the curve is flat there), whereas a low-V̇/Q̇ unit pushing PO2 down to 60 mmHg drops saturation and content substantially (the curve is steep there). Blood from high- and low-V̇/Q̇ regions mixes in the pulmonary veins, and content — not partial pressure — averages. A little shunt-like blood therefore contaminates arterial oxygen disproportionately, while CO2 (whose dissociation curve is more linear and whose exchange is more sensitive to total ventilation via chemoreceptor feedback) is more easily compensated by hyperventilating the good units. This explains a hallmark clinical sign: V̇/Q̇ mismatch causes hypoxemia with normal or even low PaCO2, whereas pure hypoventilation raises both abnormalities together.

Step 3 — The gravitational V̇/Q̇ gradient. In an upright lung, both ventilation and perfusion increase from apex to base, but perfusion increases far more steeply because pulmonary arterial pressure is low (~15 mmHg mean) and barely overcomes the hydrostatic column of blood at the apex, while gravity actively augments flow at the base (West's zones 1–3 of the lung). Alveoli at the apex are also more distended at rest (higher transpulmonary pressure) so they expand less on inspiration, giving them lower ventilation per unit volume than mid-lung alveoli — but still far more ventilation, relatively, than the blood they receive. Net effect: apex V̇/Q̇ ≈ 3.3, base V̇/Q̇ ≈ 0.63, whole-lung mean ≈ 0.8 (values from West's classic studies, upright at rest). This creates a physiological "shunt-like" defect at the base and "dead-space-like" waste at the apex even in perfectly healthy lungs — the reason a young healthy adult's alveolar-arterial O2 gradient is never quite zero (normally 5–15 mmHg).

Step 4 — Hypoxic pulmonary vasoconstriction (HPV): the active correction. When alveolar PO2 falls locally (airway obstruction, atelectasis, regional hypoventilation), the smooth muscle of small pulmonary arterioles supplying that region constricts — the opposite of the vasodilation hypoxia produces in systemic vessels. The trigger is alveolar (not blood) PO2, sensed by the arteriolar smooth muscle and adjacent oxygen-sensing cells; the leading mechanistic model involves mitochondria in pulmonary vascular smooth muscle acting as oxygen sensors, hypoxia inhibiting voltage-gated potassium (Kv) channels, membrane depolarization, opening of voltage-gated calcium channels, calcium influx, and myosin light-chain-kinase-driven contraction — independent of the endothelium-derived-relaxing-factor pathways governing systemic vasodilation. The result: blood is diverted away from the hypoxic (poorly ventilated) region toward better-ventilated regions, restoring local V̇/Q̇ matching at the cost of a modest overall rise in pulmonary vascular resistance. HPV is graded, reversible, and most powerful when the hypoxic region is small (a lobe or segment); when hypoxia is global (high altitude, or generalized alveolar hypoventilation), HPV constricts the whole pulmonary vasculature, raising pulmonary artery pressure and contributing to pulmonary hypertension and, chronically, right ventricular strain (cor pulmonale).

Step 5 — Complementary airway-side matching. A parallel, weaker mechanism operates on the airway side: local hypocapnia (low CO2, from blood flow exceeding ventilation... actually the reverse — from ventilation exceeding perfusion needs) causes bronchoconstriction in that region, redirecting air toward better-perfused alveoli, and local hypercapnia causes bronchodilation. This CO2-mediated airway response is physiologically real but quantitatively much weaker than HPV, so HPV is considered the dominant active matching mechanism.

John West's radioactive-xenon studies (1960s, Hammersmith Hospital / UC San Diego). Before West's work, physiologists knew from theory that ventilation and perfusion should vary with lung height, but no one had measured regional V̇/Q̇ directly in intact, upright humans. West and colleagues had subjects inhale or intravenously receive radioactive xenon-133 (¹³³Xe), a gas essentially insoluble in blood, and used external scintillation counters positioned over different lung zones to track its distribution. For ventilation, subjects inhaled ¹³³Xe-labeled air and the initial regional count rate reflected the volume of fresh gas reaching each zone. For perfusion, ¹³³Xe dissolved in saline was injected intravenously; because it is poorly soluble, it comes out of solution and enters alveolar gas almost quantitatively on first pass through the pulmonary capillaries, so the count rate over each region reflected blood flow to that region. By taking the ratio of the two independently measured profiles at each lung height, West produced the first direct experimental confirmation of the apex-to-base ventilation and perfusion gradients, and calculated regional V̇/Q̇ ratios spanning roughly 0.6 at the base to over 3 at the apex in upright humans — values now textbook standard and cited above. Crucially, this showed the gradient in perfusion is steeper than the gradient in ventilation, explaining why V̇/Q̇ falls from apex to base rather than staying uniform, and why even healthy lungs have measurable alveolar-arterial O2 gradients.

The three-zone model and its mechanical basis. West additionally proposed (and later confirmed with balloon-catheter pressure measurements) a three-zone model explaining why perfusion gradients are so steep: in zone 1 (uppermost lung, seen only in disease or severe hypovolemia) alveolar pressure can exceed pulmonary arterial pressure, collapsing capillaries and abolishing flow; in zone 2 (mid-upper lung) arterial pressure exceeds alveolar pressure which exceeds venous pressure, so flow is governed by the arterial-alveolar pressure difference (a "waterfall" or Starling-resistor effect); in zone 3 (lower lung) both arterial and venous pressures exceed alveolar pressure, and flow is governed by the usual arterial-venous pressure difference, further augmented by vascular distension under high hydrostatic pressure. This mechanistic zone model, validated against direct measurements of alveolar and vascular pressures in animal and human lungs, explains the quantitative shape of the perfusion gradient West's xenon studies revealed.

The Multiple Inert Gas Elimination Technique (MIGET) — Wagner, Naumann, West (1970s). The xenon method gave spatial resolution but only two-point (V and Q) information. Peter Wagner and John West developed MIGET to reconstruct the entire continuous distribution of V̇/Q̇ ratios in a lung, spatial location aside. Subjects (or animals) are infused intravenously with a mixture of six inert gases of differing blood solubility (e.g., sulfur hexafluoride, ethane, cyclopropane, halothane, diethyl ether, acetone), each gas's retention in blood (arterial concentration relative to mixed venous) depending mathematically on both its solubility and the V̇/Q̇ ratio of the units it passes through. By measuring the retention and excretion of all six gases simultaneously and fitting a 50-compartment mathematical model, Wagner and West could recover, non-invasively, the continuous distribution of ventilation and perfusion across the full range of V̇/Q̇ ratios in a real, intact lung — including quantifying true shunt and dead-space fractions separately from low- and high-V̇/Q̇ mismatch. Applied to patients with COPD, ARDS, and pulmonary embolism, MIGET proved definitively that the hypoxemia in most lung diseases arises predominantly from V̇/Q̇ mismatch (broadening and bimodal splitting of the distribution) rather than from diffusion limitation across a thickened membrane, settling a long clinical debate and providing the quantitative basis for modern mechanical ventilation strategy.

Example 1 — Alveolar-arterial O2 gradient reveals shunt versus hypoventilation. A 68-year-old patient breathing room air (FiO2 = 0.21, barometric pressure 760 mmHg, PH2O 47 mmHg) has arterial blood gases: PaO2 = 55 mmHg, PaCO2 = 60 mmHg. Is this simple hypoventilation, or is V̇/Q̇ mismatch also present? Calculate expected alveolar PO2 using the alveolar gas equation: PAO2 = FiO2 × (Pb − PH2O) − PaCO2/R PAO2 = 0.21 × (760 − 47) − 60/0.8 PAO2 = 0.21 × 713 − 75 = 149.7 − 75 = 74.7 mmHg The alveolar-arterial (A-a) gradient = PAO2 − PaO2 = 74.7 − 55 ≈ 20 mmHg. Normal A-a gradient for this age is roughly (age/4) + 4 ≈ 21 mmHg, so this gradient is essentially at the upper limit of normal — meaning the hypoxemia here is explained almost entirely by hypoventilation (elevated PaCO2 driving down PAO2), not by significant additional V̇/Q̇ mismatch. Contrast this with a patient of the same age with PaO2 = 55 and PaCO2 = 40 (normal): PAO2 = 149.7 − 50 = 99.7, A-a gradient = 99.7 − 55 ≈ 45 mmHg — far above normal, implicating substantial V̇/Q̇ mismatch or shunt as the cause. This calculation, routine in clinical practice, is a direct bedside application of the V̇/Q̇ framework: it separates "not enough total ventilation" from "air and blood not meeting properly."

Example 2 — Pulmonary embolism: a physiological experiment in dead space. A previously healthy 30-year-old develops sudden dyspnea after a long flight. A large embolus occludes the right lower lobe pulmonary artery. Reason through the consequences using V̇/Q̇ logic. Immediately after occlusion, the right lower lobe alveoli continue to be ventilated (airways are unaffected) but receive no blood flow: V̇/Q̇ → ∞ in that region — pure alveolar dead space. Two things follow. First, that ventilation is wasted (it doesn't participate in gas exchange), so the fraction of each breath reaching functional exchange units drops, tending to raise PaCO2 unless compensated. Second — counterintuitively — this dead-space-only defect does not by itself cause severe hypoxemia, because the blood that would have flowed through the embolized region is redirected (by simple vascular resistance changes, and later reinforced somewhat by regional hypocapnic bronchoconstriction) to still-perfused regions, which then become relatively overperfused for their ventilation (low V̇/Q̇), creating a secondary mismatch that does cause hypoxemia. Clinically, the patient hyperventilates (dyspnea, anxiety, hypoxemia-driven chemoreceptor stimulation), which usually keeps PaCO2 normal or low despite the dead-space fraction, so the classic finding in acute PE is hypoxemia with a widened A-a gradient and normal-to-low PaCO2 — precisely the "mismatch signature" distinguished from hypoventilation in Example 1. Massive PE additionally reduces cardiac output, dropping mixed venous PO2, which worsens any residual shunt-like regions further (lower venous O2 content makes each admixture of shunted blood more desaturating) — illustrating how V̇/Q̇ physiology interacts with cardiac output, not just lung mechanics.

John B. West (1928–2020) trained originally in Australia and New Zealand, then spent most of his career at the Hammersmith Hospital in London and later UC San Diego, where he became one of the most influential respiratory physiologists of the twentieth century. He combined an unusual dual identity: a meticulous experimentalist willing to use radioactive isotopes, balloon catheters, and elaborate multi-gas infusions on human subjects, and a lucid theoretician who built the mathematical models (the three-zone lung, the V̇/Q̇ distribution algorithms behind MIGET) that turned raw measurements into a coherent, quantitative picture of lung function. He was also a mountaineer-physiologist, leading the American Medical Research Expedition to Everest (1981) that made direct measurements of human physiology at extreme altitude, tying his V̇/Q̇ work directly into questions of hypoxic adaptation.

Mechanical ventilation in intensive care is designed explicitly around V̇/Q̇ principles: strategies like prone positioning in ARDS work partly by redistributing perfusion toward previously dependent, better-ventilated lung regions, improving matching without changing total ventilation or oxygen delivery. Positive end-expiratory pressure (PEEP) recruits collapsed (shunt-like, V̇/Q̇ = 0) alveoli back into ventilation, converting shunt into functional low-V̇/Q̇ units that at least respond to supplemental oxygen. Diagnosis of pulmonary embolism historically relied on ventilation-perfusion (V/Q) scintigraphy scans — a direct clinical descendant of West's xenon methodology — imaging regions of ventilation without perfusion. Anesthesiologists manage one-lung ventilation during thoracic surgery by exploiting HPV, sometimes pharmacologically blunting or preserving it depending on whether oxygenation or surgical exposure is the priority. High-altitude and diving medicine use V̇/Q̇ concepts to explain high-altitude pulmonary edema (exaggerated, patchy HPV causing localized capillary stress failure) and to understand why chronic hypoxic pulmonary vasoconstriction in COPD and interstitial lung disease drives pulmonary hypertension and right heart strain (cor pulmonale). In veterinary and comparative physiology, understanding species differences in HPV strength and pulmonary vascular architecture informs research on diving mammals and high-altitude adapted species, connecting directly to broader Respiratory Adaptations across environments, and the framework generalizes conceptually to any distributed exchange organ, echoing themes from Circulatory Systems and reinforcing why Gas Exchange & Diffusion alone cannot explain real-world arterial blood gases.

Ask the tutor: How would chronic hypoxic pulmonary vasoconstriction from living at high altitude or from severe COPD lead to right heart failure (cor pulmonale)?